{
    "Trade/Device Name(s)": [
        "Randox Microalbumin Control Level 1 and Level 2 (Liquid)",
        "Microalbumin Control Level 1 and Level 2"
    ],
    "Submitter Information": "Randox Laboratories Limited",
    "510(k) Number": "K121746",
    "Predicate Device Reference 510(k) Number(s)": [
        "K072835"
    ],
    "Regulatory Class": "Class I, reserved",
    "Product Code(s)": [
        "JJX"
    ],
    "Summary Letter Date": "June 14, 2012",
    "Summary Letter Received Date": "June 14, 2012",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Single (Specified) Analyte Controls (Assayed)"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Microalbumin",
        "Albumin"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [
        ""
    ],
    "Instrument(s)/Platform(s)": [
        "Hitachi 717",
        "Cobas Mira",
        "RX Daytona",
        "Dimension"
    ],
    "Method(s)/Technology(ies)": [
        ""
    ],
    "Methodologies": [
        ""
    ],
    "Submission Type(s)": [
        "Control",
        "Quality control material"
    ],
    "Document Summary": "FDA 510(k) summary for Randox Microalbumin Control Level 1 and Level 2 (Liquid), single-analyte quality control materials for albumin in human urine",
    "Indications for Use Summary": "Designed for use as assayed quality control materials for the quantitative determination of albumin in human urine; for prescription use only by professionals.",
    "fda_folder": "Clinical Chemistry"
}